Albemarle Corporation

New York Stock Exchange
Back to all articles
Neutral 0

Seeking Clues to Albemarle (ALB) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

AI-generated analysis

📉 Albemarle (ALB) closed at $194.04, dropping 1.35% and underperforming the broader S&P 500 which gained 0.29%.

📊 Despite the daily decline, ALB shares posted a 10.45% gain over the previous month, outpacing the Basic Materials sector's 1.95% advance.

🗓️ The company is scheduled to release its Q1 earnings report on May 6, 2026, with analysts projecting EPS of $1.24.

📈 Revenue forecasts for the upcoming quarter stand at $1.33 billion, representing a projected 23.05% increase year-over-year.

📅 Annual Zacks Consensus Estimates anticipate earnings of $8.72 per share and total revenue of $5.8 billion for the full year.

💡 Analyst forecasts have recently shifted positively, with the consensus EPS projection moving 7.01% higher in the past 30 days.

🏆 Albemarle currently holds a Zacks Rank of #3 (Hold), based on proprietary analysis integrating recent estimate changes.

📊 The stock trades at a Forward P/E ratio of 22.55, which is above the industry average of 19.63 for Basic Materials peers.

🤲 Valuation metrics show a PEG ratio of 1.41 compared to an industry average of 1.58, indicating slightly lower expected growth relative to price.

🏭 The Chemical - Diversified industry is ranked #152 out of over 250 industries, placing it in the bottom 38% of all sectors.

📉 Top-rated Zacks Industries historically outperform the bottom half by a factor of 2 to 1 based on historical performance data.

📈 The Zacks Rank model has a track record since 1988 showing that #1 Strong Buy stocks produce an average annual return of +25%.

🤖 Wall Street and investors will closely monitor upcoming earnings to validate current projections against actual financial results.

📉 If the recent stock price underperformance continues, it may reflect broader market headwinds rather than specific company issues given sector outperformance.

💼 Management has not provided new commentary beyond standard analyst consensus estimates at this time.

🔍 Investors are encouraged to track estimate revisions on Zacks.com for updated ratings and future trading recommendations.

📉 The stock's current price action contrasts with the strong monthly gain, highlighting short-term volatility or sector rotation pressures.

💰 The significant projected EPS growth of 788.89% suggests analysts expect a major reset in earnings per share for Q1.

🌍 Market context shows ALB lagging both the Dow and Nasdaq while slightly missing the S&P 500 gain today.

📊 Industry rankings suggest that despite individual company strength, the broader chemical sector faces headwinds relative to other industries.

Bullish Signals
  • The stock has witnessed a significant gain of 10.45% over the previous month, outperforming the Basic Materials sector which saw only a 1.95% gain.
  • Analysts project that EPS will reach $1.24 for the upcoming quarter, representing an impressive 788.89% increase from the prior-year quarter.
  • Revenue is expected to rise to $1.33 billion in Q1 2026, reflecting a substantial 23.05% growth from the equivalent quarter last year.
  • Annual consensus estimates anticipate earnings of $8.72 per share and revenue of $5.8 billion, signifying a massive +1203.8% shift in EPS projections from the previous year.
  • Recent consensus EPS projections have moved 7.01% higher within the past 30 days, indicating positive analyst sentiment and upward revisions to forecasts.
  • The PEG ratio of 1.41 is more favorable than the industry average of 1.58, suggesting the stock may be undervalued relative to its expected earnings growth.
  • Albemarle trades at a Forward P/E ratio of 22.55, which allows for significant growth potential while maintaining a valuation comparable to industry peers.
Risk Factors
  • Albemarle (ALB) recently underperformed the broader market, falling short of the S&P 500's gain while also trailing its own sector peers despite a monthly increase.
  • The company is trading at a Forward P/E ratio of 22.55, which is a significant premium compared to its industry average of 19.63, suggesting overvaluation relative to peers.
  • Albemarle currently holds a Zacks Rank of #3 (Hold), a mid-tier rating that does not reflect strong investor optimism and indicates average or uncertain growth potential.
  • The company's PEG ratio of 1.41 is below the industry average of 1.58, but given the high earnings projection implied by the current valuation, investors may be concerned about future growth realization.
  • The Chemical - Diversified industry ALB operates in ranks only 152 out of over 250 industries, placing it in the bottom 38% of all industries which historically underperforms.
  • Analysts have not provided a consensus buy recommendation, as evidenced by the mid-range Zacks Rank, signaling caution regarding upcoming earnings on May 6, 2026.
Full Analysis
Albemarle Corporation (ALB) shares closed at $194.04, marking a 1.35% decline from the previous session and trailing the S&P 500's 0.29% gain, though the stock had posted a 10.45% increase over the prior month. The broader market showed mixed performance with the Dow Jones falling 0.31% and the Nasdaq rising 0.89%. As a specialty chemicals company, ALB outperformed its Basic Materials sector peers, which gained 1.95%, but still lagged behind the S&P 500's stronger showing of 10.54%. Investors are anticipating the company's upcoming earnings disclosure scheduled for May 6, 2026, during which analysts project an EPS of $1.24, representing a massive 788.89% year-over-year increase, alongside revenue estimates of $1.33 billion, a 23.05% rise from the previous quarter. For the full fiscal year, Zacks Consensus Estimates forecast earnings of $8.72 per share and revenue of $5.8 billion, translating to projected shifts of +1203.8% and +12.87% respectively compared to the last year. Recent data indicates that the consensus EPS projection has moved 7.01% higher in the past 30 days. Albemarle currently holds a Zacks Rank of #3, categorized as a Hold, which sits in the middle of the proprietary rating system ranging from #1 (Strong Buy) to #5 (Strong Sell). The stock trades at a Forward P/E ratio of 22.55, positioning it above the industry average of 19.63 for Basic Materials, while its PEG ratio stands at 1.41 compared to an industry average of 1.58. Further valuation context places Albemarle within the Chemical - Diversified industry, which holds a Zacks Industry Rank of 152, placing it in the bottom 38% of all 250+ industries ranked by Zacks. Research cited indicates that top-rated industries tend to outperform the bottom half by a factor of 2 to 1. The article highlights that adjustments to analyst forecasts often correlate with future stock price movements and suggests utilizing these metrics on zacks.com for upcoming trading sessions. The content concludes with promotional material for a free stock analysis report containing Zacks Investment Research's recommendations for the next 30 days.